RE:RE:2022maybe it has something to do with that it is from a prospectus from February 2021 in this period also the results for phase 1 were published. the Q3 is already long gone, but this could also mean that there could be an announcement every day. Unique Cannabinoid Purification The Company currently purifies unique cannabinoids from natural sources. Current activities are small scale and used for research and development activities. The scale up of these activities will require the purchase of unique cannabis biomass containing targeted cannabinoids. The Company is currently working with customers to narrow objectives of unique cannabinoid commercialization. The total project cost is approximately $1,000,000 of which approximately $200,000 has been incurred to date. Remaining project deliverables including required biomass will cost approximately $800,000. Commercial activities for this project are expected to commence in Q3 2021. DR. Nadir Arber says he wants to finish the study by the end of the year.
But today I found this https://clinicaltrials.gov/ct2/show/NCT04969172
it says study end for phase 2 July 2022... what's going on there ?
Phase 2 was already completed in Greece in August?